Blog

Ciox Health’s Data Utilities boost clinical data accuracy, insight, and value derived from chart retrievals

 Ciox Health™, a leading health technology company, today announced the release of Ciox Data Utilities™. Ciox Data…

BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio

Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated…

Endoscopy Operative Devices Market Size Worth $11.7 Billion By 2028: Grand View Research, Inc.

The global endoscopy operative devices market size is expected to reach USD 11.7 billion by 2028, according to a new report…

Clearlake Capital-Backed nThrive Completes Acquisition of TransUnion’s Healthcare Business

nThrive, Inc. (“nThrive”), a healthcare revenue cycle management (“RCM”) software-as-a-service (“SaaS”) platform provider, backed by Clearlake…

New England College of Optometry Partners with Noodle to Build a Distance Education Doctor of Optometry Program

 The New England College of Optometry (NECO), the longest continually operating college of optometry in the country, today…

Induced Pluripotent Stem Cells Production Market to grow by USD 1.55 billion

Technavio’s latest offering Induced Pluripotent Stem Cells Production Market report provides a detailed analysis on the competitive…

Novarad and PenRad partner to provide further diagnostic tracking functionality to healthcare providers

– Novarad, a leading provider of medical software, announced today that it has expanded its strategic partnership…

COVID-19 Takes a Toll on People with Blood Cancers and Disorders

 As the COVID-19 pandemic continues to evolve, five studies being presented during the 63rd American Society…

HealthTrackRx Retains FDA Emergency Use Authorization for COVID-19 Testing

HealthTrackRx, the leading polymerase chain reaction (PCR) testing lab, today confirmed that it has retained Emergency Use…

Viracta Therapeutics Presents Preclinical Vecabrutinib Data in Oral and Poster Presentations at ASH 2021

 Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the presentation of new…